Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Hepatocellular | 37 | 2024 | 2214 | 6.390 |
Why?
|
Liver Neoplasms | 41 | 2024 | 4253 | 5.610 |
Why?
|
Liver Cirrhosis | 38 | 2024 | 1862 | 4.560 |
Why?
|
Hepatitis C, Chronic | 10 | 2020 | 1031 | 2.470 |
Why?
|
Aspirin | 10 | 2024 | 3283 | 2.000 |
Why?
|
Fatty Liver | 3 | 2024 | 727 | 1.850 |
Why?
|
Liver | 15 | 2024 | 7475 | 1.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2023 | 3255 | 1.150 |
Why?
|
Hepatitis B, Chronic | 2 | 2020 | 393 | 1.040 |
Why?
|
Liver Diseases | 3 | 2024 | 1253 | 0.990 |
Why?
|
GTP-Binding Proteins | 2 | 2019 | 970 | 0.960 |
Why?
|
End Stage Liver Disease | 3 | 2024 | 314 | 0.960 |
Why?
|
Sweden | 10 | 2022 | 1341 | 0.950 |
Why?
|
Cardiovascular Diseases | 14 | 2022 | 15160 | 0.920 |
Why?
|
Antiviral Agents | 7 | 2022 | 2987 | 0.860 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2021 | 1131 | 0.840 |
Why?
|
Adiposity | 4 | 2021 | 1806 | 0.800 |
Why?
|
Risk Factors | 48 | 2022 | 72296 | 0.760 |
Why?
|
Hepatorenal Syndrome | 1 | 2021 | 61 | 0.760 |
Why?
|
Somatotypes | 1 | 2020 | 42 | 0.750 |
Why?
|
Hepatic Encephalopathy | 1 | 2021 | 139 | 0.730 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 979 | 0.710 |
Why?
|
Risk Reduction Behavior | 4 | 2020 | 1125 | 0.700 |
Why?
|
Esophageal and Gastric Varices | 1 | 2021 | 207 | 0.680 |
Why?
|
Peritonitis | 1 | 2021 | 365 | 0.680 |
Why?
|
Coronary Artery Disease | 5 | 2022 | 6486 | 0.680 |
Why?
|
Biopsy | 13 | 2024 | 6755 | 0.660 |
Why?
|
Eicosanoids | 1 | 2020 | 279 | 0.650 |
Why?
|
Dyslipidemias | 2 | 2016 | 849 | 0.650 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 11726 | 0.640 |
Why?
|
Proportional Hazards Models | 17 | 2022 | 12356 | 0.620 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2021 | 293 | 0.590 |
Why?
|
Metabolic Diseases | 1 | 2023 | 658 | 0.580 |
Why?
|
Intra-Abdominal Fat | 3 | 2021 | 591 | 0.580 |
Why?
|
Simvastatin | 1 | 2019 | 360 | 0.580 |
Why?
|
Obesity | 12 | 2023 | 12746 | 0.560 |
Why?
|
Hepatitis, Autoimmune | 3 | 2023 | 141 | 0.560 |
Why?
|
Cohort Studies | 25 | 2023 | 40559 | 0.550 |
Why?
|
Natural Language Processing | 1 | 2024 | 1041 | 0.540 |
Why?
|
Humans | 108 | 2024 | 744366 | 0.540 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2282 | 0.530 |
Why?
|
Fluorenes | 2 | 2017 | 160 | 0.520 |
Why?
|
Heart Arrest | 2 | 2023 | 1470 | 0.520 |
Why?
|
Uridine Monophosphate | 1 | 2015 | 70 | 0.520 |
Why?
|
Middle Aged | 61 | 2024 | 213390 | 0.510 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1178 | 0.500 |
Why?
|
Adult | 49 | 2024 | 214052 | 0.500 |
Why?
|
Incidence | 16 | 2023 | 20952 | 0.490 |
Why?
|
Biliary Tract Neoplasms | 3 | 2022 | 178 | 0.490 |
Why?
|
Atrial Fibrillation | 2 | 2023 | 5035 | 0.490 |
Why?
|
Prospective Studies | 29 | 2023 | 53290 | 0.490 |
Why?
|
Fibrosis | 5 | 2023 | 2029 | 0.480 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1790 | 0.480 |
Why?
|
Follow-Up Studies | 22 | 2024 | 39052 | 0.480 |
Why?
|
Clostridium perfringens | 1 | 2013 | 27 | 0.470 |
Why?
|
Heart Failure | 4 | 2022 | 10895 | 0.470 |
Why?
|
Coffee | 2 | 2019 | 578 | 0.460 |
Why?
|
Weight Gain | 2 | 2021 | 2293 | 0.460 |
Why?
|
Hepacivirus | 3 | 2015 | 1379 | 0.460 |
Why?
|
Female | 70 | 2024 | 380193 | 0.440 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 2873 | 0.440 |
Why?
|
Primary Prevention | 1 | 2020 | 1167 | 0.440 |
Why?
|
Male | 62 | 2024 | 350115 | 0.410 |
Why?
|
Secondary Prevention | 1 | 2018 | 1530 | 0.400 |
Why?
|
Hemolysis | 1 | 2013 | 420 | 0.400 |
Why?
|
Benzimidazoles | 2 | 2017 | 850 | 0.390 |
Why?
|
Aged | 38 | 2024 | 163288 | 0.390 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2148 | 0.370 |
Why?
|
Diet | 7 | 2023 | 7937 | 0.370 |
Why?
|
Resuscitation | 1 | 2015 | 658 | 0.370 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 2535 | 0.360 |
Why?
|
Stroke | 3 | 2023 | 9981 | 0.350 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1223 | 0.350 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2020 | 3070 | 0.350 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.350 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2200 | 0.330 |
Why?
|
Blood Transfusion | 1 | 2015 | 1301 | 0.320 |
Why?
|
Hepatitis C | 2 | 2015 | 1591 | 0.320 |
Why?
|
Interleukin-6 | 1 | 2018 | 3203 | 0.320 |
Why?
|
Catheterization | 1 | 2013 | 1470 | 0.310 |
Why?
|
Drug Costs | 1 | 2015 | 1105 | 0.300 |
Why?
|
Insulin Resistance | 2 | 2021 | 3864 | 0.290 |
Why?
|
Aspartate Aminotransferases | 2 | 2019 | 418 | 0.290 |
Why?
|
Body Mass Index | 9 | 2021 | 12721 | 0.290 |
Why?
|
Clostridium Infections | 1 | 2013 | 548 | 0.280 |
Why?
|
Bacteremia | 1 | 2013 | 963 | 0.280 |
Why?
|
Cross Infection | 1 | 2015 | 1417 | 0.280 |
Why?
|
Nurses | 3 | 2021 | 2462 | 0.270 |
Why?
|
Risk Assessment | 11 | 2021 | 23336 | 0.270 |
Why?
|
Registries | 6 | 2022 | 8091 | 0.270 |
Why?
|
Crohn Disease | 1 | 2018 | 2304 | 0.260 |
Why?
|
Disease Progression | 7 | 2023 | 13286 | 0.260 |
Why?
|
Cholangiocarcinoma | 2 | 2020 | 516 | 0.250 |
Why?
|
Exercise | 2 | 2023 | 5615 | 0.240 |
Why?
|
Bile Duct Neoplasms | 2 | 2019 | 567 | 0.240 |
Why?
|
Heart | 1 | 2017 | 4464 | 0.230 |
Why?
|
Severity of Illness Index | 8 | 2022 | 15535 | 0.220 |
Why?
|
Hepatitis, Viral, Human | 1 | 2023 | 138 | 0.220 |
Why?
|
Comorbidity | 6 | 2021 | 10388 | 0.210 |
Why?
|
Death Certificates | 1 | 2023 | 169 | 0.210 |
Why?
|
Bradycardia | 1 | 2023 | 307 | 0.200 |
Why?
|
Biliary Tract | 1 | 2022 | 134 | 0.200 |
Why?
|
United States | 17 | 2023 | 69872 | 0.200 |
Why?
|
Ascites | 2 | 2021 | 344 | 0.200 |
Why?
|
Life Style | 3 | 2022 | 3835 | 0.200 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7182 | 0.200 |
Why?
|
Colitis, Lymphocytic | 1 | 2021 | 25 | 0.190 |
Why?
|
Colitis, Collagenous | 1 | 2021 | 26 | 0.190 |
Why?
|
Feeding Behavior | 3 | 2022 | 3188 | 0.190 |
Why?
|
Prevalence | 5 | 2021 | 15221 | 0.190 |
Why?
|
Laxatives | 1 | 2021 | 87 | 0.190 |
Why?
|
Sports Medicine | 1 | 2023 | 225 | 0.190 |
Why?
|
Nuts | 2 | 2019 | 257 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15520 | 0.180 |
Why?
|
Clinical Coding | 1 | 2021 | 171 | 0.180 |
Why?
|
Double-Blind Method | 3 | 2024 | 12025 | 0.180 |
Why?
|
Sulfonylurea Compounds | 1 | 2021 | 205 | 0.180 |
Why?
|
Gallstones | 1 | 2022 | 286 | 0.180 |
Why?
|
Gastrointestinal Motility | 1 | 2021 | 225 | 0.170 |
Why?
|
Young Adult | 9 | 2024 | 56429 | 0.170 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 174 | 0.170 |
Why?
|
Waist Circumference | 2 | 2020 | 917 | 0.170 |
Why?
|
Alcohol Drinking | 3 | 2020 | 3966 | 0.170 |
Why?
|
Catheter Ablation | 1 | 2012 | 2758 | 0.170 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2020 | 188 | 0.170 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2021 | 161 | 0.160 |
Why?
|
Massachusetts | 3 | 2021 | 8662 | 0.160 |
Why?
|
Dietary Fiber | 2 | 2019 | 760 | 0.160 |
Why?
|
International Classification of Diseases | 1 | 2024 | 867 | 0.160 |
Why?
|
Propensity Score | 3 | 2021 | 1781 | 0.160 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.160 |
Why?
|
Gallbladder Neoplasms | 1 | 2019 | 182 | 0.160 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12244 | 0.160 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2021 | 262 | 0.150 |
Why?
|
Thinness | 1 | 2021 | 480 | 0.150 |
Why?
|
Thiazolidinediones | 1 | 2021 | 476 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2020 | 548 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2021 | 415 | 0.150 |
Why?
|
Obesity, Abdominal | 2 | 2021 | 361 | 0.150 |
Why?
|
Diet Surveys | 1 | 2021 | 1173 | 0.150 |
Why?
|
Age of Onset | 2 | 2021 | 3270 | 0.150 |
Why?
|
Prognosis | 8 | 2021 | 29060 | 0.150 |
Why?
|
Adolescent | 9 | 2024 | 85779 | 0.150 |
Why?
|
Retrospective Studies | 10 | 2023 | 77460 | 0.150 |
Why?
|
Case-Control Studies | 8 | 2023 | 21748 | 0.150 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57776 | 0.150 |
Why?
|
Human Growth Hormone | 1 | 2022 | 683 | 0.150 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10943 | 0.140 |
Why?
|
Inflammation | 3 | 2023 | 10637 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1572 | 0.140 |
Why?
|
Overweight | 3 | 2023 | 2371 | 0.140 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 25039 | 0.140 |
Why?
|
Platelet Count | 1 | 2019 | 780 | 0.140 |
Why?
|
Hyperammonemia | 1 | 2017 | 76 | 0.140 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 711 | 0.140 |
Why?
|
Hormones | 1 | 2020 | 889 | 0.140 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2428 | 0.130 |
Why?
|
Consensus | 2 | 2024 | 2960 | 0.130 |
Why?
|
Logistic Models | 3 | 2019 | 13409 | 0.130 |
Why?
|
Dairy Products | 1 | 2019 | 498 | 0.130 |
Why?
|
Benzamides | 1 | 2021 | 1379 | 0.130 |
Why?
|
Reproduction | 1 | 2020 | 668 | 0.130 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2016 | 194 | 0.130 |
Why?
|
Administration, Oral | 1 | 2023 | 3914 | 0.130 |
Why?
|
Diastole | 1 | 2017 | 791 | 0.130 |
Why?
|
Alanine Transaminase | 1 | 2017 | 592 | 0.120 |
Why?
|
Paracentesis | 1 | 2015 | 95 | 0.120 |
Why?
|
Anthropometry | 1 | 2019 | 1350 | 0.120 |
Why?
|
Warfarin | 1 | 2023 | 1497 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1157 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2021 | 1359 | 0.120 |
Why?
|
Piperacillin | 1 | 2013 | 41 | 0.120 |
Why?
|
Thrombophilia | 1 | 2016 | 305 | 0.120 |
Why?
|
Glutamine | 1 | 2017 | 579 | 0.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5223 | 0.120 |
Why?
|
Penicillanic Acid | 1 | 2013 | 45 | 0.110 |
Why?
|
Lipid Metabolism | 2 | 2019 | 1889 | 0.110 |
Why?
|
Coma | 1 | 2017 | 475 | 0.110 |
Why?
|
Clindamycin | 1 | 2013 | 139 | 0.110 |
Why?
|
Risk | 3 | 2020 | 9688 | 0.110 |
Why?
|
Blood Component Transfusion | 1 | 2013 | 143 | 0.110 |
Why?
|
Walking | 1 | 2020 | 1180 | 0.110 |
Why?
|
Genotype | 2 | 2019 | 12952 | 0.110 |
Why?
|
Algorithms | 2 | 2024 | 13882 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1002 | 0.110 |
Why?
|
Albumins | 1 | 2015 | 568 | 0.100 |
Why?
|
Creatinine | 1 | 2017 | 1919 | 0.100 |
Why?
|
Rhode Island | 1 | 2012 | 347 | 0.100 |
Why?
|
Postmenopause | 1 | 2020 | 2460 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1579 | 0.100 |
Why?
|
Atherosclerosis | 2 | 2017 | 3444 | 0.090 |
Why?
|
Body Weight | 1 | 2021 | 4671 | 0.090 |
Why?
|
Vancomycin | 1 | 2013 | 501 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14723 | 0.090 |
Why?
|
Premature Birth | 1 | 2021 | 1721 | 0.090 |
Why?
|
Lipids | 2 | 2022 | 3307 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2213 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3582 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 868 | 0.080 |
Why?
|
Survival Rate | 4 | 2020 | 12788 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2013 | 1851 | 0.080 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2020 | 295 | 0.080 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13104 | 0.080 |
Why?
|
DNA, Viral | 1 | 2014 | 2227 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2861 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6933 | 0.080 |
Why?
|
Indoles | 1 | 2016 | 1839 | 0.080 |
Why?
|
Anticoagulants | 1 | 2023 | 4600 | 0.080 |
Why?
|
Regression Analysis | 1 | 2017 | 6459 | 0.070 |
Why?
|
Virus Replication | 1 | 2015 | 2535 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3759 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3475 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2015 | 1771 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3309 | 0.070 |
Why?
|
Child | 3 | 2022 | 77709 | 0.070 |
Why?
|
Chronic Disease | 1 | 2020 | 9145 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 13991 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6542 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 2016 | 0.060 |
Why?
|
Survival Analysis | 2 | 2021 | 10252 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2013 | 1199 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3666 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5099 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5263 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7147 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4459 | 0.060 |
Why?
|
Vegetables | 2 | 2020 | 1182 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 21696 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2400 | 0.060 |
Why?
|
Smoking | 1 | 2019 | 8987 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8319 | 0.050 |
Why?
|
Sex Factors | 3 | 2020 | 10400 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3208 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2019 | 2971 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8551 | 0.050 |
Why?
|
Dietary Fats | 2 | 2020 | 2016 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2023 | 310 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7282 | 0.050 |
Why?
|
Growth Hormone | 1 | 2023 | 705 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2017 | 63107 | 0.050 |
Why?
|
Delphi Technique | 1 | 2024 | 779 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 40075 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.050 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 103 | 0.050 |
Why?
|
Chemoprevention | 1 | 2022 | 319 | 0.050 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 49 | 0.040 |
Why?
|
Poultry | 1 | 2019 | 82 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2022 | 4576 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2019 | 111 | 0.040 |
Why?
|
Meat Products | 1 | 2019 | 99 | 0.040 |
Why?
|
Ampulla of Vater | 1 | 2019 | 141 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 175 | 0.040 |
Why?
|
Republic of Korea | 1 | 2021 | 538 | 0.040 |
Why?
|
Autopsy | 1 | 2023 | 1020 | 0.040 |
Why?
|
Bile Ducts | 1 | 2020 | 284 | 0.040 |
Why?
|
Trans Fatty Acids | 1 | 2019 | 153 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2019 | 517 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2019 | 226 | 0.040 |
Why?
|
2-Naphthylamine | 1 | 2017 | 23 | 0.040 |
Why?
|
Macrocyclic Compounds | 1 | 2017 | 72 | 0.040 |
Why?
|
Sodium Benzoate | 1 | 2017 | 15 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1025 | 0.040 |
Why?
|
Medicare | 1 | 2015 | 6566 | 0.040 |
Why?
|
Phenylacetates | 1 | 2017 | 114 | 0.040 |
Why?
|
Glycemic Index | 1 | 2019 | 394 | 0.040 |
Why?
|
Fishes | 1 | 2019 | 569 | 0.040 |
Why?
|
Uracil | 1 | 2017 | 165 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2017 | 416 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6489 | 0.030 |
Why?
|
Carbamates | 1 | 2017 | 196 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 577 | 0.030 |
Why?
|
Siblings | 1 | 2020 | 854 | 0.030 |
Why?
|
Valine | 1 | 2017 | 413 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 320 | 0.030 |
Why?
|
Ritonavir | 1 | 2017 | 322 | 0.030 |
Why?
|
Proline | 1 | 2017 | 458 | 0.030 |
Why?
|
Glutamates | 1 | 2017 | 398 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6539 | 0.030 |
Why?
|
Pancreas | 1 | 2022 | 1687 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 711 | 0.030 |
Why?
|
Anilides | 1 | 2017 | 408 | 0.030 |
Why?
|
Interferons | 1 | 2018 | 706 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 927 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2560 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19905 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 16715 | 0.030 |
Why?
|
Spine | 1 | 2021 | 1144 | 0.030 |
Why?
|
Fruit | 1 | 2019 | 1142 | 0.030 |
Why?
|
Animals | 4 | 2021 | 168768 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1195 | 0.030 |
Why?
|
Age Factors | 2 | 2020 | 18373 | 0.030 |
Why?
|
Cesarean Section | 1 | 2021 | 1365 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1536 | 0.030 |
Why?
|
Lymphoma | 1 | 2022 | 1877 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2015 | 640 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 700 | 0.030 |
Why?
|
Menopause | 1 | 2020 | 1626 | 0.030 |
Why?
|
Bariatric Surgery | 1 | 2022 | 952 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2795 | 0.020 |
Why?
|
Genetic Loci | 1 | 2021 | 2575 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10259 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2021 | 2050 | 0.020 |
Why?
|
Lipoproteins | 1 | 2015 | 878 | 0.020 |
Why?
|
Trauma Centers | 1 | 2016 | 891 | 0.020 |
Why?
|
Brain | 1 | 2017 | 26388 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 29144 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1813 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3280 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2017 | 812 | 0.020 |
Why?
|
Bone Density | 1 | 2021 | 3468 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1940 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2453 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5101 | 0.020 |
Why?
|
Cholesterol | 1 | 2015 | 2919 | 0.020 |
Why?
|
Viral Load | 1 | 2015 | 3300 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15078 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8432 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16367 | 0.010 |
Why?
|
Critical Illness | 1 | 2016 | 2670 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9312 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2016 | 3680 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5692 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5316 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12262 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12802 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25628 | 0.010 |
Why?
|
Veterans | 1 | 2015 | 2519 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7730 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11718 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41005 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20130 | 0.010 |
Why?
|